Narcolepsy is a chronic, debilitating sleep disorder first described in the late 19th century which is characterized by cataplexy i.e. sudden transient muscular weakness, sleep paralysis, disturbed night sleep and excessive daytime sleepiness. Narcolepsy is caused by deficiencies in hypothalamic hypocretin (also known as orexin) neurotransmission, most likely through autoimmune-mediated postnatal cell death of hypocretin producing neurons. Hypocretin is a neuropeptide hormone that is responsible for for controlling appetite and sleep patterns.
Prevalence studies have shown that genetic factors play a role on narcolepsy but are neither necessary nor sufficient to cause narcolepsy. Twin studies show that only 25 – 30% of twins are concordant. Family studies show that the risk of developing narcolepsy for a first degree relative of a patient is only 1 – 2%. This is however 30 – 40 times higher than the estimated prevalence of narcolepsy in the general population, showing that genetic heritability does play a role. The HLA-DQB1*06:02 allele on the DRB1*15:01 – DQA1*01:02 – DQB1*06:02 haplotype has been shown to be one of the most important predisposing genetic factors with 85 to 95% of cataplexy narcolepsy patients carrying this haplotype. Persons homozygous for HLA-DQB1*06:02 carry a greater risk than heterozygous persons, though persons heterozygous for HLA-DQB1*03:01 and HLA-DQB1*06:02 are also at increased risk. HLA-DQB1*05:01 and DQB1*06:01 are thought to be protective for narcolepsy. HLA-DQB1*06:02 has a larger P4 pocket which would facilitate binding of larger hydrophobic residues compared to HLA-DQB1*06:01 and this may help explain the opposite effects these two allele have on narcolepsy susceptibility.
The genetic risk of developing narcolepsy is not however fully explained by HLA-DQB1*06:02 as there are many patients with narcolepsy who do not carry HLA-DQB1*06:02, pointing to the possibility of non HLA gene involvement. Candidate genes include the different hypocretin system genes, though initial studies have not shown an association and TNFα gene polymorphisms.
Genetic testing for narcolepsy, particularly, HLA-DQB1*06:02 typing is useful as an aid to diagnosis in patients with cataplexy but the association is not specific as there are many narcolepsy patients with HLA-DQB1*06:02 and many HLA-DQB1*06:02 persons who do not have narcolepsy.
Do you or someone you know suffer from Narcolepsy or are you a researcher working in this area? Please join the conversation. Leave a comment. Thanks.
If you find this website useful, why not buy the eBook for only $19.99.
You get all the content of this website and a whole lot more on HLA in one easy to read pdf format. You have access to all the articles even when offline and you can print at your leisure. In addition, you will be making a valuable contribution to the upkeep of this site.
Thank you. Delordson Kallon.